메뉴 건너뛰기




Volumn 14, Issue 11, 2014, Pages 1-7

Role of B Lymphocytes in the Pathogenesis of Type 1 Diabetes

Author keywords

Antigen presentation; B lymphocyte; Immune pathology

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; RECEPTOR OCCUPANCY; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MOLECULARLY TARGETED THERAPY; NONOBESE DIABETIC MOUSE; PATHOLOGY; PATHOPHYSIOLOGY;

EID: 84920817159     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0543-8     Document Type: Review
Times cited : (39)

References (55)
  • 1
    • 0029826977 scopus 로고    scopus 로고
    • B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice
    • COI: 1:CAS:528:DyaK28XmvFait78%3D, PID: 8920894
    • Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med. 1996;184(5):2049–53.
    • (1996) J Exp Med , vol.184 , Issue.5 , pp. 2049-2053
    • Serreze, D.V.1    Chapman, H.D.2    Varnum, D.S.3    Hanson, M.S.4    Reifsnyder, P.C.5    Richard, S.D.6
  • 2
    • 36849027817 scopus 로고    scopus 로고
    • Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
    • COI: 1:CAS:528:DC%2BD2sXhsValsL%2FP, PID: 18060033
    • Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, Wong FS, et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest. 2007;117(12):3857–67.
    • (2007) J Clin Invest , vol.117 , Issue.12 , pp. 3857-3867
    • Hu, C.Y.1    Rodriguez-Pinto, D.2    Du, W.3    Ahuja, A.4    Henegariu, O.5    Wong, F.S.6
  • 3
    • 43049171493 scopus 로고    scopus 로고
    • B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions
    • COI: 1:CAS:528:DC%2BD1cXit1OlurY%3D, PID: 18292508
    • Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, Pop SM, et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol. 2008;180(5):2863–75.
    • (2008) J Immunol , vol.180 , Issue.5 , pp. 2863-2875
    • Xiu, Y.1    Wong, C.P.2    Bouaziz, J.D.3    Hamaguchi, Y.4    Wang, Y.5    Pop, S.M.6
  • 4
    • 58149359257 scopus 로고    scopus 로고
    • Targeting CD22 reprograms B-cells and reverses autoimmune diabetes
    • COI: 1:CAS:528:DC%2BD1MXhsleisrk%3D, PID: 18689692
    • Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, et al. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes. 2008;57(11):3013–24. doi:10.2337/db08-0420.
    • (2008) Diabetes , vol.57 , Issue.11 , pp. 3013-3024
    • Fiorina, P.1    Vergani, A.2    Dada, S.3    Jurewicz, M.4    Wong, M.5    Law, K.6
  • 6
    • 71849093408 scopus 로고    scopus 로고
    • In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice
    • COI: 1:CAS:528:DC%2BD1cXhtl2gsLrP, PID: 19018006
    • Zekavat G, Rostami SY, Badkerhanian A, Parsons RF, Koeberlein B, Yu M, et al. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol. 2008;181(11):8133–44.
    • (2008) J Immunol , vol.181 , Issue.11 , pp. 8133-8144
    • Zekavat, G.1    Rostami, S.Y.2    Badkerhanian, A.3    Parsons, R.F.4    Koeberlein, B.5    Yu, M.6
  • 7
    • 0035889964 scopus 로고    scopus 로고
    • B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice
    • COI: 1:CAS:528:DC%2BD3MXotlamtrk%3D, PID: 11698422
    • Hulbert C, Riseili B, Rojas M, Thomas JW. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol. 2001;167(10):5535–8.
    • (2001) J Immunol , vol.167 , Issue.10 , pp. 5535-5538
    • Hulbert, C.1    Riseili, B.2    Rojas, M.3    Thomas, J.W.4
  • 8
    • 70449480577 scopus 로고    scopus 로고
    • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
    • COI: 1:CAS:528:DC%2BD1MXhsFSnsbnP, PID: 19940299, Seminal clinical study shows that anti-CD20 (Rituximab) therapy, which by broadly depleting B cells can delay disease progression in new onset human patients
    • Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009;361(22):2143–52. Seminal clinical study shows that anti-CD20 (Rituximab) therapy, which by broadly depleting B cells can delay disease progression in new onset human patients.
    • (2009) N Engl J Med , vol.361 , Issue.22 , pp. 2143-2152
    • Pescovitz, M.D.1    Greenbaum, C.J.2    Krause-Steinrauf, H.3    Becker, D.J.4    Gitelman, S.E.5    Goland, R.6
  • 10
    • 0041689676 scopus 로고    scopus 로고
    • Predominant autoantibody production by early human B cell precursors
    • COI: 1:CAS:528:DC%2BD3sXmvFeltbo%3D, PID: 12920303
    • Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374–7. doi:10.1126/science.1086907.
    • (2003) Science , vol.301 , Issue.5638 , pp. 1374-1377
    • Wardemann, H.1    Yurasov, S.2    Schaefer, A.3    Young, J.W.4    Meffre, E.5    Nussenzweig, M.C.6
  • 11
    • 84876731066 scopus 로고    scopus 로고
    • Antigen and cytokine receptor signals guide the development of the naive mature B cell repertoire
    • COI: 1:CAS:528:DC%2BC3sXoslOltA%3D%3D, PID: 22941591
    • Rowland SL, Tuttle K, Torres RM, Pelanda R. Antigen and cytokine receptor signals guide the development of the naive mature B cell repertoire. Immunol Res. 2013;55(1–3):231–40. doi:10.1007/s12026-012-8366-7.
    • (2013) Immunol Res , vol.55 , Issue.1-3 , pp. 231-240
    • Rowland, S.L.1    Tuttle, K.2    Torres, R.M.3    Pelanda, R.4
  • 12
    • 33748992038 scopus 로고    scopus 로고
    • Receptor editing in lymphocyte development and central tolerance
    • COI: 1:CAS:528:DC%2BD28XhtVSgurnP, PID: 16998507
    • Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6(10):728–40. doi:10.1038/nri1939.
    • (2006) Nat Rev Immunol , vol.6 , Issue.10 , pp. 728-740
    • Nemazee, D.1
  • 13
    • 0034608364 scopus 로고    scopus 로고
    • Revising B cell receptors
    • COI: 1:CAS:528:DC%2BD3cXjvFyntL4%3D, PID: 10839798
    • Nemazee D, Weigert M. Revising B cell receptors. J Exp Med. 2000;191(11):1813–7.
    • (2000) J Exp Med , vol.191 , Issue.11 , pp. 1813-1817
    • Nemazee, D.1    Weigert, M.2
  • 14
    • 77955916272 scopus 로고    scopus 로고
    • Molecular underpinning of B-cell anergy
    • COI: 1:CAS:528:DC%2BC3cXhtFKrtbzF, PID: 20727040
    • Yarkoni Y, Getahun A, Cambier JC. Molecular underpinning of B-cell anergy. Immunol Rev. 2010;237(1):249–63. doi:10.1111/j.1600-065X.2010.00936.x.
    • (2010) Immunol Rev , vol.237 , Issue.1 , pp. 249-263
    • Yarkoni, Y.1    Getahun, A.2    Cambier, J.C.3
  • 15
    • 74649085316 scopus 로고    scopus 로고
    • B cell activation versus anergy; the antigen receptor as a molecular switch
    • COI: 1:CAS:528:DC%2BC3cXhtlegtrg%3D, PID: 19808046
    • Cambier JC, Getahun A. B cell activation versus anergy; the antigen receptor as a molecular switch. Immunol Lett. 2010;128(1):6–7. doi:10.1016/j.imlet.2009.09.006.
    • (2010) Immunol Lett , vol.128 , Issue.1 , pp. 6-7
    • Cambier, J.C.1    Getahun, A.2
  • 16
    • 34547193611 scopus 로고    scopus 로고
    • B-cell anergy: from transgenic models to naturally occurring anergic B cells?
    • COI: 1:CAS:528:DC%2BD2sXotFahtLo%3D, PID: 17641666
    • Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol. 2007;7(8):633–43.
    • (2007) Nat Rev Immunol , vol.7 , Issue.8 , pp. 633-643
    • Cambier, J.C.1    Gauld, S.B.2    Merrell, K.T.3    Vilen, B.J.4
  • 17
    • 27544458293 scopus 로고    scopus 로고
    • Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling
    • COI: 1:CAS:528:DC%2BD2MXhtFamsb7L, PID: 16200069
    • Gauld SB, Benschop RJ, Merrell KT, Cambier JC. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol. 2005;6(11):1160–7.
    • (2005) Nat Immunol , vol.6 , Issue.11 , pp. 1160-1167
    • Gauld, S.B.1    Benschop, R.J.2    Merrell, K.T.3    Cambier, J.C.4
  • 18
    • 46149085377 scopus 로고    scopus 로고
    • Understanding B-cell tolerance through the use of immunoglobulin transgenic models
    • COI: 1:CAS:528:DC%2BD1cXntVOlsbo%3D, PID: 17943232
    • Kumar KR, Mohan C. Understanding B-cell tolerance through the use of immunoglobulin transgenic models. Immunol Res. 2008;40(3):208–23. doi:10.1007/s12026-007-8008-7.
    • (2008) Immunol Res , vol.40 , Issue.3 , pp. 208-223
    • Kumar, K.R.1    Mohan, C.2
  • 19
    • 0031897046 scopus 로고    scopus 로고
    • Positive versus negative signaling by lymphocyte antigen receptors
    • COI: 1:CAS:528:DyaK1cXisl2ntb0%3D, PID: 9597145
    • Healy JI, Goodnow CC. Positive versus negative signaling by lymphocyte antigen receptors. Annu Rev Immunol. 1998;16:645–70. doi:10.1146/annurev.immunol.16.1.645.
    • (1998) Annu Rev Immunol , vol.16 , pp. 645-670
    • Healy, J.I.1    Goodnow, C.C.2
  • 20
    • 1842476272 scopus 로고    scopus 로고
    • B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice
    • COI: 1:CAS:528:DC%2BD2cXivVShu7w%3D, PID: 15067092
    • Silveira PA, Dombrowsky J, Johnson E, Chapman HD, Nemazee D, Serreze DV. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol. 2004;172(8):5086–94.
    • (2004) J Immunol , vol.172 , Issue.8 , pp. 5086-5094
    • Silveira, P.A.1    Dombrowsky, J.2    Johnson, E.3    Chapman, H.D.4    Nemazee, D.5    Serreze, D.V.6
  • 21
    • 78649603355 scopus 로고    scopus 로고
    • Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a beta-cell neo-self-antigen in type 1 diabetes prone NOD mice
    • COI: 1:CAS:528:DC%2BC3cXhsVOktbnP, PID: 21108464, Prior studies of NOD B cell tolerance using mice transgenic for both anti-hen egg lysozyme (HEL) BCR and HEL autoantigen expressed HEL systemically. Here autoantigen expression is driven by the insulin promoter and confined to the pancreas. Thus, it is a far more physiologically relevant model to understand the roots of T1D pathogenesis
    • Cox SL, Stolp J, Hallahan NL, Counotte J, Zhang W, Serreze DV, et al. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a beta-cell neo-self-antigen in type 1 diabetes prone NOD mice. Eur J Immunol. 2010;40(12):3413–25. doi:10.1002/eji.201040817. Prior studies of NOD B cell tolerance using mice transgenic for both anti-hen egg lysozyme (HEL) BCR and HEL autoantigen expressed HEL systemically. Here autoantigen expression is driven by the insulin promoter and confined to the pancreas. Thus, it is a far more physiologically relevant model to understand the roots of T1D pathogenesis.
    • (2010) Eur J Immunol , vol.40 , Issue.12 , pp. 3413-3425
    • Cox, S.L.1    Stolp, J.2    Hallahan, N.L.3    Counotte, J.4    Zhang, W.5    Serreze, D.V.6
  • 22
    • 33744924210 scopus 로고    scopus 로고
    • Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse
    • COI: 1:CAS:528:DC%2BD28Xlt1CltLY%3D, PID: 16751358
    • Quinn 3rd WJ, Noorchashm N, Crowley JE, Reed AJ, Noorchashm H, Naji A, et al. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J Immunol. 2006;176(12):7159–64.
    • (2006) J Immunol , vol.176 , Issue.12 , pp. 7159-7164
    • Quinn, W.J.1    Noorchashm, N.2    Crowley, J.E.3    Reed, A.J.4    Noorchashm, H.5    Naji, A.6
  • 23
    • 33845398322 scopus 로고    scopus 로고
    • Identification of anergic B cells within a wild-type repertoire
    • COI: 1:CAS:528:DC%2BD2sXisFeiug%3D%3D, PID: 17174121
    • Merrell KT, Benschop RJ, Gauld SB, Aviszus K, Decote-Ricardo D, Wysocki LJ, et al. Identification of anergic B cells within a wild-type repertoire. Immunity. 2006;25(6):953–62.
    • (2006) Immunity , vol.25 , Issue.6 , pp. 953-962
    • Merrell, K.T.1    Benschop, R.J.2    Gauld, S.B.3    Aviszus, K.4    Decote-Ricardo, D.5    Wysocki, L.J.6
  • 24
    • 17044400224 scopus 로고    scopus 로고
    • The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11
    • COI: 1:CAS:528:DC%2BD2MXivFKitbc%3D, PID: 15814708
    • Rolf J, Motta V, Duarte N, Lundholm M, Berntman E, Bergman ML, et al. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol. 2005;174(8):4821–7.
    • (2005) J Immunol , vol.174 , Issue.8 , pp. 4821-4827
    • Rolf, J.1    Motta, V.2    Duarte, N.3    Lundholm, M.4    Berntman, E.5    Bergman, M.L.6
  • 25
    • 0033977135 scopus 로고    scopus 로고
    • Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice
    • COI: 1:CAS:528:DC%2BD3cXos1yrtQ%3D%3D, PID: 10607490
    • Wither JE, Roy V, Brennan LA. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice. Clin Immunol. 2000;94(1):51–63. doi:10.1006/clim.1999.4806.
    • (2000) Clin Immunol , vol.94 , Issue.1 , pp. 51-63
    • Wither, J.E.1    Roy, V.2    Brennan, L.A.3
  • 26
    • 0035013708 scopus 로고    scopus 로고
    • Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens
    • COI: 1:CAS:528:DC%2BD3MXktVantLc%3D, PID: 11371363
    • Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001;14(5):617–29.
    • (2001) Immunity , vol.14 , Issue.5 , pp. 617-629
    • Martin, F.1    Oliver, A.M.2    Kearney, J.F.3
  • 27
    • 1642536499 scopus 로고    scopus 로고
    • Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells
    • COI: 1:CAS:528:DC%2BD2cXnvVen, PID: 14707050
    • Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol. 2004;172(2):803–11.
    • (2004) J Immunol , vol.172 , Issue.2 , pp. 803-811
    • Attanavanich, K.1    Kearney, J.F.2
  • 28
    • 59649105484 scopus 로고    scopus 로고
    • RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes
    • COI: 1:CAS:528:DC%2BD1MXosFCn, PID: 19075293
    • Panigrahi AK, Goodman NG, Eisenberg RA, Rickels MR, Naji A, Luning Prak ET. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med. 2008;205(13):2985–94. doi:10.1084/jem.20082053.
    • (2008) J Exp Med , vol.205 , Issue.13 , pp. 2985-2994
    • Panigrahi, A.K.1    Goodman, N.G.2    Eisenberg, R.A.3    Rickels, M.R.4    Naji, A.5    Luning Prak, E.T.6
  • 29
    • 84855369247 scopus 로고    scopus 로고
    • Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant
    • COI: 1:CAS:528:DC%2BC3MXhs1GltrfI, PID: 22105996, Seminal work showing a human PTPN22 variant is capable of altering the integrity of B cell tolerance and ultimately increasing the risk of T1D
    • Habib T, Funk A, Rieck M, Brahmandam A, Dai X, Panigrahi AK, et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol. 2012;188(1):487–96. doi:10.4049/jimmunol.1102176. Seminal work showing a human PTPN22 variant is capable of altering the integrity of B cell tolerance and ultimately increasing the risk of T1D.
    • (2012) J Immunol , vol.188 , Issue.1 , pp. 487-496
    • Habib, T.1    Funk, A.2    Rieck, M.3    Brahmandam, A.4    Dai, X.5    Panigrahi, A.K.6
  • 30
    • 72249122333 scopus 로고    scopus 로고
    • Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
    • PID: 19741189
    • Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2009;32(12):2269–74. doi:10.2337/dc09-0934.
    • (2009) Diabetes Care , vol.32 , Issue.12 , pp. 2269-2274
    • Orban, T.1    Sosenko, J.M.2    Cuthbertson, D.3    Krischer, J.P.4    Skyler, J.S.5    Jackson, R.6
  • 31
    • 36749011882 scopus 로고    scopus 로고
    • The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
    • COI: 1:CAS:528:DC%2BD2sXht1KgtLfM, PID: 17942684
    • Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007;104(43):17040–5. doi:10.1073/pnas.0705894104.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , Issue.43 , pp. 17040-17045
    • Wenzlau, J.M.1    Juhl, K.2    Yu, L.3    Moua, O.4    Sarkar, S.A.5    Gottlieb, P.6
  • 32
    • 84856689949 scopus 로고    scopus 로고
    • Development of autoantibodies in the TrialNet Natural History Study
    • PID: 21750277
    • Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, et al. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care. 2011;34(9):1897–901. doi:10.2337/dc11-0560.
    • (2011) Diabetes Care , vol.34 , Issue.9 , pp. 1897-1901
    • Vehik, K.1    Beam, C.A.2    Mahon, J.L.3    Schatz, D.A.4    Haller, M.J.5    Sosenko, J.M.6
  • 33
    • 0142061950 scopus 로고    scopus 로고
    • The prevalence of insulin autoantibodies at the onset of type 1 diabetes is higher in males than females during adolescence
    • COI: 1:CAS:528:DC%2BD3sXnvVCguro%3D, PID: 13680123
    • Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bingley PJ. The prevalence of insulin autoantibodies at the onset of type 1 diabetes is higher in males than females during adolescence. Diabetologia. 2003;46(10):1354–6. doi:10.1007/s00125-003-1197-2.
    • (2003) Diabetologia , vol.46 , Issue.10 , pp. 1354-1356
    • Williams, A.J.1    Norcross, A.J.2    Dix, R.J.3    Gillespie, K.M.4    Gale, E.A.5    Bingley, P.J.6
  • 34
    • 0023722804 scopus 로고
    • Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age
    • COI: 1:STN:280:DyaL1M7js1Ohtw%3D%3D, PID: 3066606
    • Vardi P, Ziegler AG, Mathews JH, Dib S, Keller RJ, Ricker AT, et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 1988;11(9):736–9.
    • (1988) Diabetes Care , vol.11 , Issue.9 , pp. 736-739
    • Vardi, P.1    Ziegler, A.G.2    Mathews, J.H.3    Dib, S.4    Keller, R.J.5    Ricker, A.T.6
  • 35
    • 0035511862 scopus 로고    scopus 로고
    • International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice
    • COI: 1:CAS:528:DC%2BD3MXotFGisr8%3D, PID: 11679421
    • Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 2001;50(11):2451–8.
    • (2001) Diabetes , vol.50 , Issue.11 , pp. 2451-2458
    • Bonifacio, E.1    Atkinson, M.2    Eisenbarth, G.3    Serreze, D.4    Kay, T.W.5    Lee-Chan, E.6
  • 36
    • 0034652317 scopus 로고    scopus 로고
    • Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes
    • COI: 1:CAS:528:DC%2BD3cXhsFCrtro%3D, PID: 10677521
    • Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A. 2000;97(4):1701–6.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , Issue.4 , pp. 1701-1706
    • Yu, L.1    Robles, D.T.2    Abiru, N.3    Kaur, P.4    Rewers, M.5    Kelemen, K.6
  • 37
    • 4644225746 scopus 로고    scopus 로고
    • Investigation of the role of B-cells in type 1 diabetes in the NOD mouse
    • COI: 1:CAS:528:DC%2BD2cXotFymtrs%3D, PID: 15448087
    • Wong FS, Wen L, Tang M, Ramanathan M, Visintin I, Daugherty J, et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes. 2004;53(10):2581–7.
    • (2004) Diabetes , vol.53 , Issue.10 , pp. 2581-2587
    • Wong, F.S.1    Wen, L.2    Tang, M.3    Ramanathan, M.4    Visintin, I.5    Daugherty, J.6
  • 38
    • 84897505588 scopus 로고    scopus 로고
    • In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis
    • COI: 1:CAS:528:DC%2BC2cXkslams74%3D, PID: 24610011, Prior to publication of this paper, insulin-specfic B cells were the only islet autoantigen specific B cells identified in the NOD mouse model. Though the importance of peripherin as a pancreatic antigen remains to be determined, the presence of the these B cells in the pancreas is an intriguing finding
    • Garabatos N, Alvarez R, Carrillo J, Carrascal J, Izquierdo C, Chapman HD, et al. In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis. J Immunol. 2014;192(7):3080–90. doi:10.4049/jimmunol.1301053. Prior to publication of this paper, insulin-specfic B cells were the only islet autoantigen specific B cells identified in the NOD mouse model. Though the importance of peripherin as a pancreatic antigen remains to be determined, the presence of the these B cells in the pancreas is an intriguing finding.
    • (2014) J Immunol , vol.192 , Issue.7 , pp. 3080-3090
    • Garabatos, N.1    Alvarez, R.2    Carrillo, J.3    Carrascal, J.4    Izquierdo, C.5    Chapman, H.D.6
  • 39
    • 0033564970 scopus 로고    scopus 로고
    • I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice
    • COI: 1:CAS:528:DyaK1MXksVegur4%3D, PID: 10395666
    • Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol. 1999;163(2):743–50.
    • (1999) J Immunol , vol.163 , Issue.2 , pp. 743-750
    • Noorchashm, H.1    Lieu, Y.K.2    Noorchashm, N.3    Rostami, S.Y.4    Greeley, S.A.5    Schlachterman, A.6
  • 40
    • 84868008849 scopus 로고    scopus 로고
    • B-cell cross-presentation of autologous antigen precipitates diabetes
    • COI: 1:CAS:528:DC%2BC38Xhsl2it7vJ, PID: 22829452, A clear demonstration of the importance of B cells in cross presenting autoantigen to self-reactive CD8+ T cells
    • Marino E, Tan B, Binge L, Mackay CR, Grey ST. B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes. 2012;61(11):2893–905. doi:10.2337/db12-0006. A clear demonstration of the importance of B cells in cross presenting autoantigen to self-reactive CD8+ T cells.
    • (2012) Diabetes , vol.61 , Issue.11 , pp. 2893-2905
    • Marino, E.1    Tan, B.2    Binge, L.3    Mackay, C.R.4    Grey, S.T.5
  • 41
    • 11844290756 scopus 로고    scopus 로고
    • Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis
    • COI: 1:CAS:528:DC%2BD2MXotFSr, PID: 15634886
    • Hussain S, Delovitch TL. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol. 2005;174(2):680–7.
    • (2005) J Immunol , vol.174 , Issue.2 , pp. 680-687
    • Hussain, S.1    Delovitch, T.L.2
  • 42
    • 0036918641 scopus 로고    scopus 로고
    • The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors
    • COI: 1:CAS:528:DC%2BD3sXjt12j, PID: 12516557
    • Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol. 2002;32(12):3657–66.
    • (2002) Eur J Immunol , vol.32 , Issue.12 , pp. 3657-3666
    • Silveira, P.A.1    Johnson, E.2    Chapman, H.D.3    Bui, T.4    Tisch, R.M.5    Serreze, D.V.6
  • 43
    • 84874885423 scopus 로고    scopus 로고
    • Tolerant anti-insulin B cells are effective APCs
    • COI: 1:CAS:528:DC%2BC3sXjsFGqtbc%3D, PID: 23396943, Though the study is largely an in vitro demonstration of antigen presentation, it does show that insulin-binding 125Tg B cells are more competent presenters of insulin peptides than their non insulin-binding counterparts. Suggesting they may be in vivo potent antigen presenting cells as well
    • Kendall PL, Case JB, Sullivan AM, Holderness JS, Wells KS, Liu E, et al. Tolerant anti-insulin B cells are effective APCs. J Immunol. 2013;190(6):2519–26. doi:10.4049/jimmunol.1202104. Though the study is largely an in vitro demonstration of antigen presentation, it does show that insulin-binding 125Tg B cells are more competent presenters of insulin peptides than their non insulin-binding counterparts. Suggesting they may be in vivo potent antigen presenting cells as well.
    • (2013) J Immunol , vol.190 , Issue.6 , pp. 2519-2526
    • Kendall, P.L.1    Case, J.B.2    Sullivan, A.M.3    Holderness, J.S.4    Wells, K.S.5    Liu, E.6
  • 44
    • 42449104350 scopus 로고    scopus 로고
    • + cytotoxic T-cell survival to enhance type 1 diabetes
    • COI: 1:CAS:528:DC%2BD1cXksVGkur4%3D, PID: 18184927
    • + cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes. 2008;57(4):909–17. doi:10.2337/db07-1256.
    • (2008) Diabetes , vol.57 , Issue.4 , pp. 909-917
    • Brodie, G.M.1    Wallberg, M.2    Santamaria, P.3    Wong, F.S.4    Green, E.A.5
  • 45
    • 42449144715 scopus 로고    scopus 로고
    • HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families
    • COI: 1:CAS:528:DC%2BD1cXksVGrsr4%3D, PID: 18252895
    • Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008;57(4):1084–92. doi:10.2337/db07-1331.
    • (2008) Diabetes , vol.57 , Issue.4 , pp. 1084-1092
    • Erlich, H.1    Valdes, A.M.2    Noble, J.3    Carlson, J.A.4    Varney, M.5    Concannon, P.6
  • 46
    • 58149299735 scopus 로고    scopus 로고
    • Analysis of islet inflammation in human type 1 diabetes
    • COI: 1:STN:280:DC%2BD1M%2FlslKltw%3D%3D, PID: 19128359
    • Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155(2):173–81. doi:10.1111/j.1365-2249.2008.03860.x.
    • (2009) Clin Exp Immunol , vol.155 , Issue.2 , pp. 173-181
    • Willcox, A.1    Richardson, S.J.2    Bone, A.J.3    Foulis, A.K.4    Morgan, N.G.5
  • 47
    • 84930791607 scopus 로고    scopus 로고
    • Insulitis in human type 1 diabetes: a comparison between patients and animal models
    • In't VP. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol. 2014. doi:10.1007/s00281-014-0438-4.
    • (2014) Semin Immunopathol
    • In't, V.P.1
  • 48
    • 60849137241 scopus 로고    scopus 로고
    • High-resolution three-dimensional imaging of islet-infiltrate interactions based on optical projection tomography assessments of the intact adult mouse pancreas
    • PID: 19021448
    • Alanentalo T, Loren CE, Larefalk A, Sharpe J, Holmberg D, Ahlgren U. High-resolution three-dimensional imaging of islet-infiltrate interactions based on optical projection tomography assessments of the intact adult mouse pancreas. J Biomed Opt. 2008;13(5):054070. doi:10.1117/1.3000430.
    • (2008) J Biomed Opt , vol.13 , Issue.5 , pp. 054070
    • Alanentalo, T.1    Loren, C.E.2    Larefalk, A.3    Sharpe, J.4    Holmberg, D.5    Ahlgren, U.6
  • 49
    • 79960088916 scopus 로고    scopus 로고
    • Insulitis in human type 1 diabetes: the quest for an elusive lesion
    • In't VP. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets. 2011;3(4):131–8.
    • (2011) Islets , vol.3 , Issue.4 , pp. 131-138
    • In't, V.P.1
  • 50
    • 0035879105 scopus 로고    scopus 로고
    • Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice
    • COI: 1:CAS:528:DC%2BD3MXotFWktbk%3D, PID: 11441119
    • Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001;167(2):1081–9.
    • (2001) J Immunol , vol.167 , Issue.2 , pp. 1081-1089
    • Tian, J.1    Zekzer, D.2    Hanssen, L.3    Lu, Y.4    Olcott, A.5    Kaufman, D.L.6
  • 51
    • 43049156086 scopus 로고    scopus 로고
    • + phenotype controls T cell-dependent inflammatory responses
    • COI: 1:CAS:528:DC%2BD1cXmtlagt78%3D, PID: 18482568
    • + phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639–50. doi:10.1016/j.immuni.2008.03.017.
    • (2008) Immunity , vol.28 , Issue.5 , pp. 639-650
    • Yanaba, K.1    Bouaziz, J.D.2    Haas, K.M.3    Poe, J.C.4    Fujimoto, M.5    Tedder, T.F.6
  • 52
    • 84898466276 scopus 로고    scopus 로고
    • Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice
    • PID: 24465383, Seminal demonstration of how tolerogenic dendritic cells may be exploited to expand a population of immunosuppressive B cells, widely referred to as B-regulatory cells (Bregs) and suppress T1D
    • Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice. PLoS One. 2014;9(1):e83575. doi:10.1371/journal.pone.0083575. Seminal demonstration of how tolerogenic dendritic cells may be exploited to expand a population of immunosuppressive B cells, widely referred to as B-regulatory cells (Bregs) and suppress T1D.
    • (2014) PLoS One , vol.9 , Issue.1 , pp. e83575
    • Di Caro, V.1    Phillips, B.2    Engman, C.3    Harnaha, J.4    Trucco, M.5    Giannoukakis, N.6
  • 53
    • 84878978312 scopus 로고    scopus 로고
    • Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells
    • COI: 1:CAS:528:DC%2BC3sXhtFOlsb7M, PID: 23716674
    • Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, Ezine S, et al. Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A. 2013;110(24):E2199–208. doi:10.1073/pnas.1222446110.
    • (2013) Proc Natl Acad Sci U S A , vol.110 , Issue.24 , pp. E2199-E2208
    • Montandon, R.1    Korniotis, S.2    Layseca-Espinosa, E.3    Gras, C.4    Megret, J.5    Ezine, S.6
  • 54
    • 79957768363 scopus 로고    scopus 로고
    • B cell-directed therapies in type 1 diabetes
    • COI: 1:CAS:528:DC%2BC3MXntFSms78%3D, PID: 21531625
    • Marino E, Silveira PA, Stolp J, Grey ST. B cell-directed therapies in type 1 diabetes. Trends Immunol. 2011;32(6):287–94. doi:10.1016/j.it.2011.03.006.
    • (2011) Trends Immunol , vol.32 , Issue.6 , pp. 287-294
    • Marino, E.1    Silveira, P.A.2    Stolp, J.3    Grey, S.T.4
  • 55
    • 84864390309 scopus 로고    scopus 로고
    • Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes
    • COI: 1:CAS:528:DC%2BC38XhtFOgu77F, PID: 22698916, Model approach of how specific targeting of B cells that recognize islet antigens effects disease development
    • Henry RA, Kendall PL, Thomas JW. Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes. Diabetes. 2012;61(8):2037–44. doi:10.2337/db11-1746. Model approach of how specific targeting of B cells that recognize islet antigens effects disease development.
    • (2012) Diabetes , vol.61 , Issue.8 , pp. 2037-2044
    • Henry, R.A.1    Kendall, P.L.2    Thomas, J.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.